We need to rethink our approach in responding to cancers in our younger women patients,” said Hope S. Rugo, MD.

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

The median time to treatment initiation across all cancer types increased from 21 days in 2004 to 28 days in 2015. The median time to treatment initiation is increasing across cancer types, and this ...

These findings support the need for a phase III randomized controlled trial to definitively determine whether the addition of an antiangiogenic to a second or even a third-generation TKI provides ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

The results of our study suggest a concerning pattern in cancer center advertising, particularly among top-ranked institutions,” researchers wrote.

Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.

Cuts to Medicare reimbursement could prevent cancer patients from accessing care and force practices to downsize or close, radiation oncologists say.

(HealthDay News) — China has promised to give $500 million to the World Health Organization (WHO) over the next 5 years, positioning itself to become the group’s top donor, The Washington Post ...

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

Some pharmacists worry that tariffs could drive companies out of business while raising prices and creating more drug ...

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.